(WHS-P23) First-in-human Clinical Study to Assess the Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients with Clean Wounds After Mohs Micrographic Surgery (MMS) for Skin Cancer

S. Deshayes, D. Griffin, A. Quach, W. Weaver, Tempo Therapeutics, San Diego, California, UNITED STATES|D. Griffin, University of Virginia, Charlotsville, Virginia, UNITED STATES|S. Martin, Cal Coast Dermatology, Encino, California, UNITED STATES|C. Hanke, Laser and Skin Surgery Center of Indiana, Carmel, Indiana, UNITED STATES|J. Hau, Cypress Dermatology, Cypress, Texas, UNITED STATES|